Omaxe Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 10,787.4 million compared to INR 4,838.6 million a year ago. Revenue was INR 10,925.6 million compared to INR 4,998.4 million a year ago. Net loss was INR 2,575.5 million compared to INR 2,424.4 million a year ago. Basic loss per share from continuing operations was INR 14.08 compared to INR 13.25 a year ago. Diluted loss per share from continuing operations was INR 14.08 compared to INR 13.25 a year ago.